ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Protech Home Medical Corporation

Protech Home Medical Corporation (PTQ)

2.06
0.00
(0.00%)
Cerrado 25 Enero 3:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
2.06
Postura de Compra
2.00
Postura de Venta
2.09
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
2.06 Rango de 52 semanas 2.06
Capitalización de Mercado [m]
Precio Anterior
2.06
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
42,102,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-26.77
Beneficio por acción (BPA)
-0.16
turnover
245.92M
Beneficio neto
-6.76M

Acerca de Protech Home Medical Corporation

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sede
Vancouver, British Columbia, Can
Fundado
-
Protech Home Medical Corporation is listed in the Surgical,med Instr,apparatus sector of the TSX Venture Exchange with ticker PTQ. The last closing price for Protech Home Medical was $2.06. Over the last year, Protech Home Medical shares have traded in a share price range of $ 2.06 to $ 2.06.

Protech Home Medical currently has 42,102,000 shares in issue. The market capitalisation of Protech Home Medical is $86.73 million. Protech Home Medical has a price to earnings ratio (PE ratio) of -26.77.

PTQ Últimas noticias

Protech Home Medical Announces Intention to Change Name and Consolidate Stock in Anticipation of Proposed NASDAQ Listing

CINCINNATI, May 11, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical equipment industry, focused...

Protech Home Medical to Participate at the Sidoti Spring Investor Conference on March 24-25

CINCINNATI, March 17, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company” or “Protech”) (TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical equipment industry...

Protech Continues Rapid Expansion with Opening of Two New Locations Focused on Respiratory Therapy Products and Services

CINCINNATI, March 16, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical equipment industry...

Protech Home Medical Reports Record First Quarter Fiscal 2021 Financial Results

Posts Revenue Growth of 32% And Adjusted EBITDA Growth of 53% Recurring Revenue Grows to 75% of Total Revenue CINCINNATI, March 02, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the...

Protech Home Medical Announces Date and Time For Q1 Fiscal 2021 Quarterly Conference Call and Audio Webcast

CINCINNATI, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company”) (TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical equipment industry, focused on...

Protech Home Medical to Present at The MicroCap Rodeo Winter Wonderland Conference

CINCINNATI, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company” or “Protech”) (TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical equipment industry, focused...

Protech Enters Florida With Accretive Acquisition of Mayhugh’s Medical Equipment

$7 Million in Annualized Revenues, in Excess of 15% Adjusted EBITDA Margin and Increases Protech’s Active Patient Count by More Than 10,000 5,000 Patients to Immediately Enter Protech’s...

Protech Home Medical Announces Date and Time for Q4 And full Year Fiscal 2020 Conference Call and Audio Webcast

CINCINNATI, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company”) (TSXV: PTQ) (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on...

Protech Home Medical Reports Strong Fourth Quarter and Record Audited Full Year Fiscal 2020 Financial Results

CINCINNATI, Ohio, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV:PTQ; OTCQX:PTQQF), a U.S. based leader in the home medical equipment industry...

Protech Home Medical Announces Date and Time for Q4 and Full Year Fiscal 2020 Conference Call and Audio Webcast

CINCINNATI, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company”) (TSXV: PTQ) (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1002.062.062.0600CS
4002.062.062.0600CS
12002.062.062.0600CS
26002.062.062.0600CS
52002.062.062.0600CS
156002.062.062.0600CS
2601.1114.5833333330.962.540.471054611.47080985CS

PTQ - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Protech Home Medical?
El precio actual de las acciones de Protech Home Medical es $ 2.06
¿Cuántas acciones de Protech Home Medical están en circulación?
Protech Home Medical tiene 42,102,000 acciones en circulación
¿Cuál es la capitalización de mercado de Protech Home Medical?
La capitalización de mercado de Protech Home Medical es CAD 86.73M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Protech Home Medical?
Protech Home Medical ha negociado en un rango de $ 2.06 a $ 2.06 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Protech Home Medical?
El ratio precio/beneficio de Protech Home Medical es -26.77
¿Cuál es el ratio de efectivo a ventas de Protech Home Medical?
El ratio de efectivo a ventas de Protech Home Medical es 0.74
¿Cuál es la moneda de reporte de Protech Home Medical?
Protech Home Medical presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Protech Home Medical?
El último ingresos anual de Protech Home Medical es USD 245.92M
¿Cuál es el último beneficio anual de Protech Home Medical?
El último beneficio anual de Protech Home Medical es USD -6.76M
¿Cuál es la dirección registrada de Protech Home Medical?
La dirección registrada de Protech Home Medical es 666 BURRARD ST, VANCOUVER, BRITISH COLUMBIA, V6C 2Z7
¿Cuál es la dirección del sitio web de Protech Home Medical?
La dirección del sitio web de Protech Home Medical es www.quipthomemedical.com
¿En qué sector industrial opera Protech Home Medical?
Protech Home Medical opera en el sector SURGICAL,MED INSTR,APPARATUS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ADEAdex Mining Inc
$ 0.01
(100.00%)
1,000
DEALPlaygon Games Inc
$ 0.02
(100.00%)
1.75M
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
15.6k
GBUGabriel Resources Ltd
$ 0.01
(100.00%)
167k
MACThemac Resources Group Ltd
$ 0.08
(60.00%)
3k
NAVNAVCO Pharmaceuticals Inc
$ 0.005
(-50.00%)
16.63k
SMAR.PSmartset Services Inc
$ 0.015
(-50.00%)
30k
ETUE2gold Inc
$ 0.005
(-50.00%)
101.7k
DDDMetavista3D Inc
$ 2.30
(-49.45%)
701.59k
MXL.HMX Gold Corp
$ 0.04
(-46.67%)
1.5k
NDANeptune Digital Assets Corp
$ 2.20
(30.18%)
5.15M
BRCBlackrock Silver Corp
$ 0.355
(-11.25%)
3.79M
TDGTDG Gold Corp
$ 0.45
(-1.10%)
3.19M
GPUSAlset AI Ventures Inc
$ 0.14
(-12.50%)
2.79M
PNGKraken Robotics Inc
$ 2.87
(0.35%)
2.69M
maddyandboomer maddyandboomer 4 minutos hace
Need a good honest company first before getting what you call good investors....and axxa ain't it....they have shown their colors and resembles red flags...not green $ signs
AXXA
Fire_starter Fire_starter 5 minutos hace
🔥🔥🔥500 BILLION FOR THE CURE TO CANCER M-RNA VACCINE🔥🔥🔥
RNAZ
Smartypants2 Smartypants2 5 minutos hace
If jurisdiction was an issue, XTI's lawyers would have brought it as a reason for dismissal previously. Maybe they did -- and the judge already ruled against them. Either way, it's very doubtful it's still an issue in this case.
XERI
jsc52033 jsc52033 5 minutos hace
but you follow the penny stocks why
BMXI
IcyGalaxy60 IcyGalaxy60 6 minutos hace
What about 500k down payement for mt.Vernon?
NBRI
gitreal gitreal 6 minutos hace
I don't invest in scams.
BMXI
doc2016 doc2016 6 minutos hace
me:



the ban on outgoing messaging from federal agencies should surprise no one. the new administration won this cycle by emphasizing it was time for changes in defense to state to homeland security to treasury to healthcare.meta and data; meta data.
of course
NVDA
jour_trader jour_trader 7 minutos hace
I believe there is an authorized generic for OxyContin, but that's not quite the same. Once generics are approved the market price will tank, just like Vyvanse will. If Elite were the only one to get the approval that is one thing, but it is not the case. Buying Elite would not stop OxyContin pricin
ELTP
mmayr mmayr 7 minutos hace
Charlie Rich * Rollin' with the Flow 1977 HQ

[yt]b9_7ByKnwWY[/yt]

https://www.youtube.com/watch?v=b9_7ByKnwWY
StockItOut StockItOut 7 minutos hace
You're wrong. That's why you hide behind "probably."
XERI
north40000 north40000 7 minutos hace
Good idea, moms. We have both MNMD and PFE in our portfolios. PFE's expensive acquisition of SGEN(very profitable for us) has been slow to bring enough revenue to the balance sheet to solve PFE's problem being termed a laggard in pharma-land. HLS in Canada terminated a contract with PFE that involve
AMRN MNMD PFE
Ms Labonte Ms Labonte 8 minutos hace
Next leg up wide open $weet$$
WEET
getmoreshares getmoreshares 8 minutos hace
Good Afternoon-- catching up on the posts!
Smartypants2 Smartypants2 9 minutos hace
You don't even know the difference between "knew" and "new," I knew it!
XERI
Monksdream Monksdream 9 minutos hace
RAIL
https://investorshub.advfn.com/uimage/uploads/2025/1/25/zlxqsIMG_4814.gif
RAIL
misterfishman misterfishman 9 minutos hace
Be careful the bird like sitting on high voltage lines lol.
IGPK
Steady_T Steady_T 9 minutos hace
Selection issues for an OLE are many.

There are the drop outs from the original trial. That selects against those who can not tolerate the drug or the titration rate.
There are those that don't choose to go into the OLE for whatever reason. That is self selection.
There
AVXL
Smartypants2 Smartypants2 10 minutos hace
Once again, you are absolutely incorrect. But at least you are consistent.
XERI
MEPinvest MEPinvest 10 minutos hace
Do you interpret that as a good thing or a bad thing? Do you think they're being ominous and distressful to investors or cooking up something good for all?
CRTG
misterfishman misterfishman 10 minutos hace
I hope so. Sometime this year.
IGPK
jsc52033 jsc52033 11 minutos hace
are you actualy invest in BMXI or is this just boad you can talk on
BMXI
juicyjuice10002 juicyjuice10002 11 minutos hace
The financial advisor was advised by the insider to buy the shares but that conversation was kept secret. Insider advising the financial advisor is more likely.
FNMA
3331 3331 11 minutos hace
BIEL: VAGUS NERVE PATENT (PENDING)
NY Post - Jan. 23, 2025
Implantable vagus nerve stimulation (VNS) devices, which can cost $50,000, have long been used to treat epilepsy, depression and stroke. That’s because jolting the vagus nerve — the longest cranial nerve in the body — can help
Monksdream Monksdream 11 minutos hace
MESO
https://investorshub.advfn.com/uimage/uploads/2025/1/25/rkzrzIMG_4813.gif
MESO

Su Consulta Reciente

Delayed Upgrade Clock